OIS-Generic-Author-Image-MALE

Larry Haimovitch

Contributing Writer

  • All
  • Deals
  • Devices and Diagnostics
  • Digital
  • Genetics
  • Pharma
Ron Schuchard

Ron Schuchard

Dr. Schuchard is a lead reviewer for ophthalmic medical devices at the Food and Drug Administration as well as a member of review teams for ...
Read More
Why ReVision Optics Shut Down

A Look Behind ReVision Optics’ Shuttered Door

By Larry Haimovitch and Richard Mark Kirkner Someday for some company, the business of selling corneal inlays to treat presbyopia could be very lucrative, but ...
Read More
How Tweaks to Iluvien Agreement Benefit Alimera, pSivida

How Tweaks to Iluvien Agreement Benefit Alimera, pSivida

A longstanding distribution agreement between Alimera Sciences and pSivida for the Iluvien intravitreal implant has been amended, much to the apparent benefit of both companies. ...
Read More

What’s Behind the Heat-up in Glaucoma Innovation

Kicking off the sixth annual Glaucoma 360-New Horizons Forum held recently in San Francisco, co-founder and co-chair Adrienne Graves boldly proclaimed, “Glaucoma is hot.” However, ...
Read More
As Novartis Ponders Alcon’s Sale, Who Is Best Owner?

As Novartis Ponders Alcon’s Sale, Who Is Best Owner?

So when does a rumor cease being a rumor and become a reality? It remains to be seen whether all the recent and persistent rumors ...
Read More
Corneal Inlays Garnering Attention – and Investment - Eye On Innovation Article - Healthegy

Corneal Inlays Garnering Attention – & Investment

Recent positive reports about two FDA-approved corneal inlays may yet give this market sector a boost heading into 2017. Irvine, CA-based AcuFocus was the first ...
Read More
OIS Eye On Innovation Article - How Hot Is MIGS? - Healthegy

How Hot is MIGS?

The string of approvals and acquisitions in the microinvasive glaucoma surgery space has been one of ophthalmology’s more promising stories. The news shone a bright ...
Read More

Is Surprising Raindrop Approval a Sign of Friendlier FDA?

One of the takeaways that ophthalmic innovators might be reading into the unexpected and somewhat sudden approval of the Raindrop Near Vision Inlay is that ...
Read More
Iridex Makes Its Move in Glaucoma - Eye On Innovation Article

Iridex Makes its Move in Glaucoma

Over the past couple of years, there has been no shortage of positive news about the glaucoma space. While minimally invasive glaucoma surgery (MIGS) has ...
Read More
How MIGS is Remaking the Glaucoma Market - Ophthalmology Innovation Summit 2015

How MIGS is Remaking the Glaucoma Market

Glaucoma is a chronic degenerative disease whose incidence increases significantly with age. According to the World Health Organization, it is the second leading cause of ...
Read More
Glaucoma Getting a Wake-Up Call

Glaucoma Getting a Wake-Up Call

SAN FRANCISCO — Thanks to a pending boom in minimally invasive glaucoma surgery (MIGS) devices, the global glaucoma device market is poised to come out ...
Read More
Calhoun Vision Stages Turnaround

Calhoun Vision Stages Turnaround

Medtech companies in ophthalmology have made some significant strides in recent months. Second Sight and Glaukos, of course, staged IPOs in their pursuit of revolutionary ...
Read More